Altis CRO, a Turkish-based contract research organization (CRO), has been offering high-quality clinical services to the pharmaceutical and biomedical industries since its establishment in 2001. With the slogan "Altis'le bir adım önde," the company has positioned itself as a leader in the pharmaceutical industry. Altis CRO's commitment to providing top-notch clinical services has garnered attention in the industry. Despite no recent disclosed investments and investors, the company continues to thrive in the pharmaceutical sector.Through its website www.altis.org, Altis CRO showcases its expertise and contributions to the research and development of pharmaceutical and biomedical products. As Altis CRO continues to solidify its presence in the industry, it stands as a potential opportunity for venture capital firms seeking to invest in the pharmaceutical research and clinical services sector. The company's longevity, focus on quality, and its strategic headquarters in Turkey make it an intriguing entity for potential investors looking to tap into the pharmaceutical market's potential.
There is no investment information
No recent news or press coverage available for Altis CRO.